The cumulative impact of type 2 diabetes and obstructive sleep apnoea on cardiovascular, liver, diabetes-related and cancer outcomes
Riley DR, Henney A, Anson M, et al.
Diabetes Obes Metab. Pub. online 11 Nov 2024.
Leggi
Finerenone, serum potassium, and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction
Chimura M, Wang X, Jhund PS, et al.
JAMA Cardiol. 2024:e244613.
Leggi
NUOVO APPUNTAMENTO SCIENTIFIC TALK AMD – 20 NOVEMBRE
Carissimi, vi diamo appuntamento alla prossima diretta Scientific Talk AMD “Il valore clinico dell'innovazione nel monitoraggio glicemico per le persone con diabete di tipo 2”. Ci ritroveremo per questo approfondimento con Vincenzo Fiore, Angela Girelli, Luigi Laviola, moderati da Paolo Di Bartolo, il 20 novembre alle ore 17.00. A seguire, il programma e il link all’iscrizione. In chiusura, dalle 18.30…
Leggi
Tirzepatide for obesity treatment and diabetes prevention
Jastreboff AM, le Roux CW, Stefanski A, et al.
N Engl J Med. Pub. online 13 Nov 2024.
Leggi
Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes
Rooney MR, Wallace AS, Echouffo Tcheugui JB, et al.
Diabetologia. Pub. online 12 Nov 2024.
Leggi
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
Zhou B, Rayner AW, Gregge EW, et al.
Lancet. 2024:S0140-6736(24)02317-1.
Leggi
Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study
Patel KV, Chunawala Z, Verma S, et al.
JACC. Pub. online 15 Nov 2024.
Leggi
Real world effectiveness of oral semaglutide: Focus on patients with type 2 diabetes older than 75 years
Baronti W, Lencioni C, Occhipinti M, et al.
Diabetes Res Clin Pract. 2024:111928.
Leggi